Not applicableUnknownNCT03632980What this trial is testingDynamic Focusing Evaluation for Prostate Cancer TreatmentWho this might be right forCancer of Prostate EDAP TMS S.A. 180
Large-scale testing (Phase 3)Study completedNCT02673151What this trial is testing68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial TreatmentWho this might be right forProstate AdenocarcinomaPSA FailureRecurrent Prostate Carcinoma Andrei Iagaru 61
Not applicableTemporarily pausedNCT06509919What this trial is testingApplication of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate CancerWho this might be right forProstate Cancer Shanghai Changzheng Hospital 1,600
Testing effectiveness (Phase 2)Ended earlyNCT03442556What this trial is testingDocetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair DeficiencyWho this might be right forATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more University of Washington 18
Testing effectiveness (Phase 2)Study completedNCT00090363What this trial is testingZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)Who this might be right forProstate Cancer AstraZeneca 447
Testing effectiveness (Phase 2)Study completedNCT01171898What this trial is testingSafety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)Who this might be right forProstate Cancer Aragon Pharmaceuticals, Inc. 127
Not applicableActive Not RecruitingNCT03891732What this trial is testingMRI Prostate for Chinese Men Being Screened for Prostate CancerWho this might be right forProstate CancerPSAMRI Chinese University of Hong Kong 690
Testing effectiveness (Phase 2)Study completedNCT00726596What this trial is testingHydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerWho this might be right forProstate Cancer Rutgers, The State University of New Jersey 64
Testing effectiveness (Phase 2)Ended earlyNCT00050297What this trial is testingYM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerWho this might be right forProstate Cancer Astellas Pharma Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430192What this trial is testingDosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to ProstatectomyWho this might be right forProstatic Neoplasms Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Study completedNCT00970203What this trial is testingDendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerWho this might be right forCancer of ProstateCancer of the ProstateNeoplasms, Prostate+4 more Roswell Park Cancer Institute 13
Testing effectiveness (Phase 2)UnknownNCT01630967What this trial is testingEfficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)Who this might be right forProstate Neoplasm British Columbia Cancer Agency 40
Not applicableUnknownNCT02524860What this trial is testingTargeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion DeviceWho this might be right forProstate Cancer Focal Healthcare Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06594926What this trial is testingWorking Out M0 Bipolar Androgen TherapyWho this might be right forProstate Cancer Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Testing effectiveness (Phase 2)Looking for participantsNCT07393867What this trial is testingAndrogen-responsive POSLUMA-guided Intra-prostatic BoostWho this might be right forIntermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer Martin T. King, MD, PhD 23
Testing effectiveness (Phase 2)Looking for participantsNCT06617481What this trial is testingPET Scan Study to Detect Prostate Cancer in Patients with Early PSA RecurrenceWho this might be right forProstate Cancer (Post Prostatectomy) AdventHealth 30
Testing effectiveness (Phase 2)Study completedNCT00082134What this trial is testingStudy of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With DocetaxelWho this might be right forHormone-refractory Prostate Cancer Genzyme, a Sanofi Company 40
Not applicableStudy completedNCT01553838What this trial is testingA Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA ValuesWho this might be right forProstate Cancer Heinrich-Heine University, Duesseldorf 185
Testing effectiveness (Phase 2)Study completedNCT01220973What this trial is testingAtorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerWho this might be right forProstate Cancer Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Looking for participantsNCT06600698What this trial is testingSafety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSAWho this might be right forProstate Cancer Milton S. Hershey Medical Center 45